(Photo by Flickr user amylovesyah, used under a Creative Commons license)
Six Delaware-based research and development initiatives received grants from the Delaware Bioscience Center for Advanced Technology (Bioscience CAT, for short). The grant amounts were undisclosed.
Brace yourself for more acronyms: these six are either the Applied Research Collaborations (ARC) or Entrepreneurial Proof of Concept (EPoC) grants.
University of Delaware Professor of Biological Sciences Patricia DeLeon was one of the six funding recipients. She’ll work with the Reproductive Associates of Delaware on diagnostic techniques aimed at identifying embryos with the highest chance of healthy pregnancies through in vitro fertilization.
Another recipient, this one from Nemours/A.I. duPont Hospital for Children, will research and develop a faster antibody discovery method. That work’s to be done by Zhengyu Ma with collaboration from ANP Technologies. The hope is that their work will lead to new drugs used to deal with increasingly diverse human diseases.
The Bioscience CAT is a program started by the Delaware Biotechnology Institute (DBI). Since its announcement in 2011, the program has served to unify and drive the academic and industrial life science communities in Delaware.
This particular grant is a boon for startups and Delaware’s academic research institutions. DBI Director Kelvin Lee offered that, thanks to the state’s support, “the Bioscience CAT grants continue to expand and build a strong pipeline for innovative, collaborative and entrepreneurial projects in the state of Delaware.”
The next round of Bioscience CAT funding is set for 2017. Grant proposals are due by 5 p.m on March 31, 2017. Those interested in applying can find more information here.